日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Antibody-Empowered Nanomedicine for Precise Biomedical Applications

抗体赋能纳米药物在精准生物医学应用中的应用

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202521428
Chen, Chen; Chen, Xinglin; Gao, Zhenhao; Sun, Meng; Yu, Yaozong; Lv, Fang; Wang, Qiujun; Zhang, Jinfeng
发表日期：2026
文献求助 收藏

Thyroid Hormone Receptor β1 and PGC1α Coordinately Regulate OPA1/MFN2-Mediated Mitochondrial Fusion and UCP1-Mediated Lipid Browning in ccRCC.

甲状腺激素受体β1和PGC1α协同调节ccRCC中OPA1/MFN2介导的线粒体融合和UCP1介导的脂质褐变。

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202508571
Meng Xiangui, Yu Tiexi, Lv Fang, Li Weiquan, Yang Hongmei, Zhang Xiaoping, Xiao Wen
信号转导
MFN2
线粒体
UCP1
OPA1
免疫/内分泌
发表日期：2026
文献求助 收藏

PDHA1 enhances resistance to ferroptosis in anoikis-resistant prostate cancer by upregulating AIFM2.

PDHA1 通过上调 AIFM2 增强抗凋亡前列腺癌细胞对铁死亡的抵抗力。

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-026-02958-7
Cong Yukun, Chen Kang, Ju Yunjie, He Qingliu, Liu Chunyu, Chen Jiawei, Lv Fang, Chen Jinyu, Li Haoran, Chen Liang, Song Yarong
肿瘤
凋亡
表观遗传
肿瘤免疫
铁死亡
细胞生物学
前列腺癌
发表日期：2026
文献求助 收藏

The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials

胰高血糖素样肽-1受体激动剂与报告的肌肉骨骼不良事件之间的关联：随机对照试验的系统评价和荟萃分析

期刊:Therapeutic Advances in Musculoskeletal Disease
影响因子:4.1
doi:10.1177/1759720X261428147
Cao, Meng; Lin, Chu; Cai, Xiaoling; Lv, Fang; Yang, Wenjia; Ji, Linong
信号转导
发表日期：2026
文献求助 收藏

Artificial intelligence-driven gastrointestinal functional assessment: multimodal imaging, digital biomarkers, and real-time monitoring

人工智能驱动的胃肠功能评估：多模态成像、数字生物标志物和实时监测

期刊:Frontiers in Physiology
影响因子:3.4
doi:10.3389/fphys.2026.1778235
Li, Liucheng; Lv, Fang; Du, Chen; Yang, Lianjun; Pa, Chengzhou; Dai, Yunrui
发表日期：2026
文献求助 收藏

Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study

1型糖尿病患者超声心动图异常及其相关因素的特征分析：一项横断面研究

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02926-y
Yang, Wenfeng; Lin, Chu; Cai, Xiaoling; Li, Zonglin; Lv, Fang; Yang, Wenjia; Liu, Geling; Yang, Xiaolin; Li, Sha; Ji, Linong
糖尿病
代谢
发表日期：2025
文献求助 收藏

FAM111B enhances glycolysis and promotes metastasis of prostate cancer by upregulating LDHA.

FAM111B 通过上调 LDHA 增强糖酵解并促进前列腺癌转移

期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2025.101227
He Qingliu, Li Haoran, Cong Yukun, Chen Kang, Cheng Lulin, Lv Fang, Zhang Pu, Ju Yunjie, Yu Zehao, Chen Jinyu, Wang Chuxiong, Song Yarong, Li Xuechao, Chen Liang, Xing Yifei
肿瘤
前列腺癌
发表日期：2025
文献求助 收藏

Efficacy and safety of zuberitamab in the treatment of primary membranous nephropathy: an observational study

祖贝利单抗治疗原发性膜性肾病的疗效和安全性：一项观察性研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1741564
Zong, Li; Wang, Sha; Zhao, Ke; Lv, Fang-Yi; Qian, Shan-Kui; Yang, Xiang-Dong
发表日期：2025
文献求助 收藏

Observation of rituximab as initial treatment in patients with minimal change disease- a retrospective study

利妥昔单抗作为微小病变糖尿病患者初始治疗的观察——一项回顾性研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1528996
Wang, Sha; Liang, Hua; Li, Lu-Yao; Cheng, Miao-Miao; Lv, Fang-Yi; Zong, Li; Zhao, Ke; Xiao, Xiao-Yan; Yang, Xiang-Dong
糖尿病
代谢
发表日期：2025
文献求助 收藏

Anti-diabetic medications and cancer: links beyond glycemic and body weight control

抗糖尿病药物与癌症：血糖和体重控制之外的联系

期刊:Precision Clinical Medicine
影响因子:5
doi:10.1093/pcmedi/pbaf028
Cao, Meng; Lin, Chu; Cai, Xiaoling; Lv, Fang; Yang, Wenjia; Ji, Linong
糖尿病
肿瘤
肿瘤免疫
代谢
发表日期：2025
文献求助 收藏